Enzyme-Mediated Bioorthogonal Cascade Catalytic Reaction for Metabolism Intervention and Enhanced Ferroptosis on Neuroblastoma
It remains a tremendous challenge to explore effective therapeutic modalities against neuroblastoma, a lethal cancer of the sympathetic nervous system with poor prognosis and disappointing treatment outcomes. Considering the limitations of conventional treatment modalities and the intrinsic vulnerability of neuroblastoma, we herein develop a pioneering sequential catalytic therapeutic system that utilizes lactate oxidase (LOx)/horseradish peroxidase (HRP)-loaded amorphous zinc metal-organic framework, named LOx/HRP-aZIF, in combination with a 3-indole-acetic acid (IAA) prodrug. On the basis of abnormal lactate accumulation that occurs in the tumor microenvironment, the cascade reaction of LOx and HRP consumes endogenous glutathione and a reduced form of nicotinamide adenine dinucleotide to achieve the first stage of killing cancer cells via antioxidative incapacitation and electron transport chain interference. Furthermore, the generation of reactive oxygen species induced by HRP and IAA through bioorthogonal catalysis promotes ferritin degradation and lipid peroxidation, ultimately provoking self-enhanced ferroptosis with positive feedback by initiating an endogenous Fenton reaction. This work highlights the superiority of the natural enzyme-dependent cascade and bioorthogonal catalytic reaction, offering a paradigm for synergistically enzyme-based metabolism-ferroptosis anticancer therapy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:146 |
---|---|
Enthalten in: |
Journal of the American Chemical Society - 146(2024), 12 vom: 27. März, Seite 8228-8241 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Qi [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antioxidants |
---|
Anmerkungen: |
Date Completed 28.03.2024 Date Revised 28.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1021/jacs.3c13165 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36960735X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36960735X | ||
003 | DE-627 | ||
005 | 20240329000747.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240313s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1021/jacs.3c13165 |2 doi | |
028 | 5 | 2 | |a pubmed24n1353.xml |
035 | |a (DE-627)NLM36960735X | ||
035 | |a (NLM)38471004 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Qi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Enzyme-Mediated Bioorthogonal Cascade Catalytic Reaction for Metabolism Intervention and Enhanced Ferroptosis on Neuroblastoma |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.03.2024 | ||
500 | |a Date Revised 28.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a It remains a tremendous challenge to explore effective therapeutic modalities against neuroblastoma, a lethal cancer of the sympathetic nervous system with poor prognosis and disappointing treatment outcomes. Considering the limitations of conventional treatment modalities and the intrinsic vulnerability of neuroblastoma, we herein develop a pioneering sequential catalytic therapeutic system that utilizes lactate oxidase (LOx)/horseradish peroxidase (HRP)-loaded amorphous zinc metal-organic framework, named LOx/HRP-aZIF, in combination with a 3-indole-acetic acid (IAA) prodrug. On the basis of abnormal lactate accumulation that occurs in the tumor microenvironment, the cascade reaction of LOx and HRP consumes endogenous glutathione and a reduced form of nicotinamide adenine dinucleotide to achieve the first stage of killing cancer cells via antioxidative incapacitation and electron transport chain interference. Furthermore, the generation of reactive oxygen species induced by HRP and IAA through bioorthogonal catalysis promotes ferritin degradation and lipid peroxidation, ultimately provoking self-enhanced ferroptosis with positive feedback by initiating an endogenous Fenton reaction. This work highlights the superiority of the natural enzyme-dependent cascade and bioorthogonal catalytic reaction, offering a paradigm for synergistically enzyme-based metabolism-ferroptosis anticancer therapy | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Antioxidants |2 NLM | |
650 | 7 | |a Horseradish Peroxidase |2 NLM | |
650 | 7 | |a EC 1.11.1.- |2 NLM | |
700 | 1 | |a Li, Xiangze |e verfasserin |4 aut | |
700 | 1 | |a Cao, Zhiyao |e verfasserin |4 aut | |
700 | 1 | |a Feng, Wei |e verfasserin |4 aut | |
700 | 1 | |a Chen, Yu |e verfasserin |4 aut | |
700 | 1 | |a Jiang, Dapeng |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of the American Chemical Society |d 1945 |g 146(2024), 12 vom: 27. März, Seite 8228-8241 |w (DE-627)NLM00000569X |x 1520-5126 |7 nnns |
773 | 1 | 8 | |g volume:146 |g year:2024 |g number:12 |g day:27 |g month:03 |g pages:8228-8241 |
856 | 4 | 0 | |u http://dx.doi.org/10.1021/jacs.3c13165 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 146 |j 2024 |e 12 |b 27 |c 03 |h 8228-8241 |